Citicoline Sodium

胞磷胆碱钠

Report date: 2026/03/26 20:00:17
NME

Base Information

Drug NameCiticoline Sodium
Drug Alias Name胞二磷胆碱钠CerAxonNicholinSomazina思考林 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsSchizophreniaBipolar DisorderMarijuana Abuse +[11] 
Global Approved IndicationsBrain Injuries
Approved Indications in ChinaBrain Injuries
Original Approved Country/TerritoryMainland China
Original Approved Date1991/01/01
Country/TerritoryCanadaUnited StatesPortugal +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesArmed Forces Institute Of CardiologySuzhou Pharmaceutical Factory
Inactive CompaniesUniversity of Texas Southwestern Medical CenterEunice Kennedy Shriver National Institute Of Child Health And Human DevelopmentNational Institute On Drug Abuse +[5] 
Active IndicationsInfant, Newborn, DiseasesBrain Injuries
Inactive IndicationsSchizophreniaBipolar DisorderMarijuana Abuse +[9] 

Other Information

ATC CodeN06BX06
Related LinksWikipediaKEGG